{
    "symbol": "RDCM",
    "quarter": 4,
    "year": 2022,
    "date": "2023-02-08 10:31:05",
    "content": "  Forward-looking statements in the conference call involve several risks and uncertainties, including, but not limited, to the Company's statements about the 5G market and industry trends, the role the Company is expected to play in the 5G transformation, sales opportunities, sales cycles, visibility, leads, pipeline and backlog, the expected impact of currency rates, the Company's market position, cash position, potential and expected growth, including scalable and profitable growth, and momentum in 2023 and thereafter, levels of recurring revenues and gross profit from such activity, its expectations with respect to research and development and sales and marketing expenses, as well as grants from the Israel Innovation Authority, the Company's expectations with respect to its relationships with Rakuten and AT&T, its ability to handle future growth and meet demand, its expectation to continue enhancing its software solutions and demand for its solutions, deployment of its 5G solutions in cloud environments and the potential benefits to its clients, its ability to capitalize on the emerging 5G opportunities and win more market share with new and existing customers, the potential of the Company\u00e2\u0080\u0099s vision and the use of artificial intelligence in its products, and its revenue guidance. Fourth quarter revenues were $12.3 million and full year revenues were $46.1 million, a 14% year-over-year growth, and we reached an inflection point for the Company, delivering a profitable year on a non-GAAP basis while generating a positive cash flow of $7 million, ending the year with a record level of cash and on a non-GAAP basis, a net income of $2.9 million. We ended the fourth quarter of 2022 with $12.3 million in revenue and a new record quarter, an increase from $11.2 million in the fourth quarter of 2021. Our gross R&D expenses for the fourth quarter of 2022 on a non-GAAP basis were $4.7 million, a decrease of $60,000 compared to the fourth quarter of 2021. Our net R&D expenses for the fourth quarter of 2022 on a non-GAAP basis were $4.5 million, similar to the fourth quarter of 2021. Sales and marketing expenses for the fourth quarter of 2022 were $2.9 million on a non-GAAP basis, an increase of $347,000 compared to the fourth quarter of 2021. G&A expenses for the fourth quarter of 2022 on a non-GAAP basis were $942,000, an increase of $105,000 compared to the fourth quarter of 2021. Operating income on a non-GAAP basis for the fourth quarter of 2022 was $608,000 compared to an operating loss of $158,000 for the fourth quarter of 2021. Net Income for the fourth quarter of 2022 on a non-GAAP basis was $1,320,000 or a net Income of $0.09 per diluted share compared to a net loss of $237,000 or a net loss of $0.02 per diluted share for the fourth quarter of 2021. On a GAAP basis, as you can see on Slide 7, our net loss for the fourth quarter of 2022 was $0.03 million, or a net loss of $0.0 per diluted share, compared to a net loss of $1.4 million, or a net loss of $0.10 per diluted share for the fourth quarter of 2021. G&A expenses for 2022 on a non-GAAP basis were $3.6 million, an increase of $301,000 compared to the entire year of 2021. Operating Income on a non-GAAP basis for 2022 was $1.1 million, compared to an operating loss of $2.1 million for 2021. Net Income for 2022 on a non-GAAP basis was $2.9 million or a net income of $0.19 per diluted share, compared to a net loss of $1.9 million, or a net loss of $0.13 per diluted share for 2021. On a GAAP basis, as you can see on Slide 7, our net loss for 2022 was $2.3 million or a net loss of $0.16 per diluted share, compared to a net loss of $5.3 million or a net loss of $0.37 per diluted share for 2021."
}